Profiel
Chris Beattie currently works at ViAqua Therapeutics Ltd., as Director from 2021 and AquaBounty Technologies, Inc., as Chief Scientific Officer from 2022.
Actieve functies van Chris Beattie
| Bedrijven | Functie | Begin |
|---|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Directeur/Bestuurslid | 01-11-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
